James Janopaul‐Naylor
Papers
1
Total Citations
6
H-Index
1
About
James Janopaul‐Naylor is a radiation oncologist and clinical researcher whose work focuses on optimizing treatment outcomes for head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). His major contributions include landmark analyses of real-world mortality following transoral robotic surgery (TORS) versus radiation therapy, using large national databases to provide critical insights beyond clinical trial settings. His most-cited study, published in 2022, examined ninety-day mortality after TORS or radiation at Commission on Cancer-accredited facilities, revealing that real-world postoperative mortality rates for OPSCC can be higher than those reported in trials, especially in patients with comorbidities. This work has been cited 6 times and underscores the importance of patient selection and treatment modality choice. Janopaul‐Naylor’s research bridges the gap between controlled trial data and everyday clinical practice, helping to guide safer, more personalized treatment decisions for head and neck cancer patients. His ongoing investigations continue to shape evidence-based approaches in radiation oncology and surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1